Policy documents that set out the principles underpinning the commissioning of medicines and technologies. Please note that documents in this folder are currently under review.
Access to NHS funding following third party funded treatment.pdf
Defining boundaries between NHS and privately funded healthcare v4.1.docx
Eoe ICB Collaborative Commissioning Policy For Excluded High Cost Drugs And Devices 2023 25
Experimental, uncertain and unproven treatments.pdf
Individual funding requests.pdf
Medicines Governance and Local Formulary Commissioning statement v1.docx
Ongoing access to treatment following completion of NHS funded trials.pdf
Ongoing access to treatment following completion of non commercially funded trials.pdf
Ongoing access to treatment following trial of treatment.pdf
Ongoing access to treatment following ending of company trials.pdf
